[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health":3,"$fep3tjzhp3hen":14},{"ok":4,"db":5,"lastOrangeBookRun":6,"lastDrugsFdaRun":9,"lastAlertsRun":12,"stale":13},true,"ok",{"status":5,"startedAt":7,"finishedAt":8,"lastOkAt":8},"2026-10-26T06:44:32.239Z","2026-10-26T06:44:53.640Z",{"status":5,"startedAt":10,"finishedAt":11,"lastOkAt":11},"2026-10-26T06:45:02.648Z","2026-10-26T06:45:13.189Z",null,false,{"tradeName":15,"ingredient":16,"applicant":17,"applicantSlug":18,"applNos":19,"loe":12,"latestLoe":12,"basis":21,"carveOutPossible":13,"openStrengths":22,"headlineStrengths":22,"headlineFallback":13,"approvalsBeforeLoe":23,"products":24,"patents":43,"exclusivities":44,"paragraphIv":45,"catalysts":47},"CEFAZOLIN IN DEXTROSE","CEFAZOLIN SODIUM","BAXTER HLTHCARE CORP","baxter-hlthcare-corp",[20],"207131","none",3,0,[25,33,38],{"key":26,"applNo":20,"productNo":27,"dosageForm":28,"route":29,"strength":30,"approvalDate":31,"rld":4,"teCode":12,"type":32,"loe":12,"basis":21,"carveOutPossible":13},"207131-001","001","SOLUTION","INTRAVENOUS","EQ 2GM BASE\u002F100ML (EQ 20MG BASE\u002FML)","2015-08-07","RX",{"key":34,"applNo":20,"productNo":35,"dosageForm":28,"route":29,"strength":36,"approvalDate":37,"rld":4,"teCode":12,"type":32,"loe":12,"basis":21,"carveOutPossible":13},"207131-002","002","EQ 1GM BASE\u002F50ML (EQ 20MG BASE\u002FML)","2021-02-01",{"key":39,"applNo":20,"productNo":40,"dosageForm":28,"route":29,"strength":41,"approvalDate":42,"rld":4,"teCode":12,"type":32,"loe":12,"basis":21,"carveOutPossible":13},"207131-003","003","EQ 3GM BASE\u002F150ML (EQ 20MG BASE\u002FML)","2024-05-31",[],[],{"asOf":12,"firstFiled":12,"entries":46},[],[]]